A61P - Specific therapeutic activity of chemical compounds or medicinal preparations

More topics under "A61P - Specific therapeutic activity of chemical compounds or medicinal preparations" (2,008,710)
A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
A61P 11 - Drugs for disorders of the respiratory system (87,767)
A61P 13 - Drugs for disorders of the urinary system (56,135)
A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
A61P 17 - Drugs for dermatological disorders (106,455)
A61P 19 - Drugs for skeletal disorders (81,981)
A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
A61P 23 - Anaesthetics (4,141)
A61P 25 - Drugs for disorders of the nervous system (183,225)
A61P 27 - Drugs for disorders of the senses (53,017)
A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
A61P 3 - Drugs for disorders of the metabolism (129,789)
A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
A61P 33 - Antiparasitic agents (21,787)
A61P 35 - Antineoplastic agents (221,099)
A61P 37 - Drugs for immunological or allergic disorders (117,141)
A61P 39 - General protective or antinoxious agents (19,019)
A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707)
A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
A61P 5 - Drugs for disorders of the endocrine system (28,908)
A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
A61P 9 - Drugs for disorders of the cardiovascular system (159,484)

Patents for A61P - Specific therapeutic activity of chemical compounds or medicinal preparations (3,181)
12/2002
12/19/2002	CA2448763A1 A pharmaceutical combination comprising either (s)-2-ethoxy-3- [4-(2-{4-methane sulfonyl oxyphenyl} ethoxy) phenyl] propanoic acid or 3-{4-[2-(4-tert- butoxy carbonyl aminophenyl)ethoxy] phenyl} -(s)-2-ethoxy propanoic acid and a sulonylurea
12/17/2002	US6495541 Tricyclic inhibitors of poly(ADP-ribose) polymerases
12/12/2002	WO2002098857A1 New indole derivatives with 5-ht6 receptor affinity
12/12/2002	US20020187994 New compounds
12/11/2002	EP1264599A1 TNF-derived peptides for use in treating oedema
12/11/2002	CN1384829A Sodium-hydrogen exchanger type 1 inhibitor crystals
12/11/2002	CN1384819A 前列腺素e类似物 E prostaglandin analogs
12/11/2002	CN1384755A Novel exendin agonist formulations and methods administration thereof
12/10/2002	US6492374 Benzofuran derivatives, their preparation and use
12/10/2002	US6492367 Sulfamato hydroxamic acid metalloprotease inhibitor
12/05/2002	WO2002096909A1 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl) -methylamine and the use thereof for the preparation of pyrrolo 2,3-pyrimidine derivatives as protein kinases inhibitors
12/05/2002	WO2002096896A1 Biologically active methylene blue derivatives
12/05/2002	WO2002096879A1 Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands
12/05/2002	WO2002096453A1 A pharmaceutical combination comprising either (s)-2-ethoxy-3 [4-(2- {4-methane sulfonyl oxyphenyl} ethoxy)phenyl] propanoic acid or 3-{4-[2- (4-tert-butoxy carbonylamino phenyl) ethoxy] phenyl}-(s)-2-ethoxy propanoic acid and insulin
12/05/2002	WO2002096435A2 Skin-permeable composition comprising a selective cyclooxygenase-2 inhibitor a monohydric alcohol
12/05/2002	WO2002096402A1 A pharmaceutical combination comprising either (s)-2-ethoxy-3- [4-(2- {4-methane sulfonyl oxyphenyl} ethoxy) phenyl] propanoic acid or 3-{4-[2- (4-tert-butoxy carbonyl aminophenyl) ethoxy] phenyl} -(s)-2-ethoxy propanoic acid and a biguanide drug
12/05/2002	CA2448643A1 A pharmaceutical combination comprising either (s)-2-ethoxy-3- [4-(2- {4-methane sulfonyl oxyphenyl} ethoxy) phenyl] propanoic acid or 3-{4-[2- (4-tert-butoxy carbonyl aminophenyl) ethoxy] phenyl} -(s)-2-ethoxy propanoic acid and a biguanide drug
12/05/2002	CA2448637A1 A pharmaceutical combination comprising either (s)-2-ethoxy-3 [4-(2- {4-methane sulfonyl oxyphenyl} ethoxy)phenyl] propanoic acid or 3-{4-[2- (4-tert-butoxy carbonylamino phenyl) ethoxy] phenyl}-(s)-2-ethoxy propanoic acid and insulin
12/05/2002	CA2448627A1 Skin-permeable composition comprising a selective cyclooxygenase-2 inhibitor a monohydric alcohol
12/03/2002	US6489330 Or a bioprecursor, or a pharmaceutically acceptable salt, phosphate ester and/or acyl derivative of such as famciclovir; prophylactic treatment for kaposi's sarcoma or aids related disease
11/2002
11/28/2002	US20020177596 2,3,4,4a,5,6-hexahydro-1H-pyrazino(1,2-a)quinoxaline derivatives; treating depression, schizophrenia; (5-hydroxytryptamine=5HT) 5HT2a antagonist or a 5HT2c agonist
11/26/2002	US6486182 Mutual prodrugs of amlodipine and atorvastatin
11/26/2002	US6486144 Method of treatment of liver tumors and pharmaceutical compositions for use therein
11/21/2002	WO2002092597A1 The citrate salt of 5, 8, 14-triazatetracyclo(10.3.1.0?2,11.04.9¿)-hexadeca-2.(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
11/21/2002	WO2002092089A1 Tartrate salts of 5,8,14-triazatetracyclo {10.3.1.0?2,11.04,9¿}-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
11/21/2002	WO2002055098A3 Latency associated peptide for providing latency to pharmaceutically active proteins
11/21/2002	CA2446988A1 The citrate salt of 5, 8, 14-triazatetracyclo(10.3.1.02,11.04.9)-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
11/20/2002	EP1258246A2 Controlled release oxycodone compositions
11/20/2002	EP1257584A2 Humanized antibodies that sequester amyloid beta peptide
11/20/2002	CN1380883A Novel derivatives and analogues of galanthamin
11/20/2002	CN1380882A C10 ester substituted taxanes as antitumor agents
11/20/2002	CN1094361C Composition comprising propolis and essential oil
11/19/2002	US6482990 Prostaglandin E analogues
11/19/2002	US6482421 Pharmaceuticals, dietary supplements and cosmetic compositions, and the use of certain mixtures for preparing a medicament or a dietary supplement for the treatment or prevention of inflammation, hypersensitivity reactions or pain
11/13/2002	EP1255751A2 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b or v1b and v1a arginine-vasopressin receptors
11/13/2002	CN1379775A Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
11/07/2002	WO2002088159A1 Pharmaceutically active uridine esters
11/07/2002	WO2002088094A1 2-iminoimidazole derivatives (1)
11/07/2002	WO2002088092A1 2-iminoimidazole derivative (2)
11/07/2002	US20020164384 Aquatic animal treatment method and composition containing pimenta extract
11/07/2002	CA2594883A1 Pharmaceutically active uridine esters
11/07/2002	CA2445861A1 Pharmaceutically active uridine esters
11/06/2002	CN1378547A 5-(2-substituted-5-heterocyclylsulphenylpyrid-3-yl)-dihydropyrazolo [4,3-d] pyrimidin 7-ones as phosphodiesterase inhibitors
11/05/2002	US6476059 Use of polycyclic 2-aminothiazole systems for the treatment of obesity
10/2002
10/31/2002	WO2002085860A1 Pyrazole derivatives for treating hiv
10/31/2002	WO2002085855A1 2-iminopyrrolidine derivatives
10/31/2002	WO2002085850A1 Cyclic amidine derivative
10/31/2002	WO2002012502A3 Anti-tnf antibodies, compositions, methods and uses
10/31/2002	US20020161000 Treating diseases resulting from tissue breakdown such as heart disease, multiple sclerosis, osteo- and rheumatoid arthritis, atherosclerosis, and osteoporosis
10/30/2002	EP1252893A1 Medicine containing anemonin as effective component for treating aseptic inflammation
10/30/2002	EP1252889A1 Remedies or preventives for pulmonary insufficiency containing diaminotrifluoromethylpyridine derivatives
10/24/2002	WO2002066019A3 Cancer treatment
10/24/2002	WO2002050065A3 Pyrazole compounds useful as protein kinase inhibitors
10/23/2002	EP1250328A1 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
10/23/2002	EP1250138A1 Fulvestrant formulation
10/23/2002	EP1159966B1 Composition for the treatment of psoriasis
10/17/2002	US20020151478 Fusion protein comprising a latency associated peptide and a proteolytic cleavage site wherein the fusion protein is associated with a pharmaceutically active agent; gene therapy; genetic engineering; antiinflammatory agents
10/17/2002	US20020150636 Anti-leishmanial activity of betel leaf extract
10/16/2002	EP1249233A1 Npyy5 antagonists
10/16/2002	EP1248785A1 Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same
10/15/2002	US6464958 Process for the preparation of suspensions of drug particles for inhalation delivery
10/10/2002	WO2002079143A1 N-phenpropylcyclopentyl-substituted glutaramide derivatives as nep inhibitors for fsad
10/10/2002	WO2002078580A1 Condom with an erectogenic composition
10/10/2002	US20020147341 Kinase inhibitor; benign prostatic hyperplasia
10/10/2002	US20020147200 Central nervous system disorders; antiserotonine agents
10/10/2002	CA2437113A1 N-phenpropylcyclopentyl-substituted glutaramide derivatives as nep inhibitors for fsad
10/09/2002	EP1247531A2 TNF-derived peptides for use in treating oedema
10/09/2002	EP1247523A1 Essential fatty acids in the prevention of cardiovascular events
10/09/2002	EP1246638A1 Use of exendins and agonists thereof for modulation of triglyceride levels and treatment of dyslipidemia
10/09/2002	EP0996622B1 Novel spiroazabicyclic heterocyclic compounds
10/09/2002	CN1373763A Pteridinones and kinase inhibitors
10/03/2002	WO2002076953A1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
10/03/2002	WO2002059127A3 Pyrazinoquinoxaline derivatives as serotonin agonists and antagonists
10/02/2002	EP1244647A1 Quinazoline derivatives as vegf inhibitors
10/02/2002	EP1244631A1 New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
10/02/2002	EP0989851B1 Self-emulsifying formulation for acidic lipophilic compounds
10/02/2002	CN1372473A Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
10/02/2002	CN1372462A Veterinary formulation for administration of a water-insoluble drug to a target animal through a water distribution system
09/2002
09/26/2002	WO2002074754A1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
09/26/2002	WO2002016611A3 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
09/26/2002	WO2001091756A3 S-methyl-dihydro-ziprasidone for treatment of psychiatric and ocular disorders
09/26/2002	US20020137766 Electrophysiological activity
09/26/2002	US20020136787 Method of treating prickly heat
09/25/2002	EP0904087B1 Phosphatidic acid-comprising compositions
09/24/2002	US6455077 Solvent extraction of herbs
09/19/2002	WO2002072090A1 Benzimidazole compounds for modulating ige and inhibiting cellular proliferation
09/19/2002	CA2441177A1 Benzimidazole compounds for modulating ige and inhibiting cellular proliferation
09/18/2002	EP1240166A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl carboxamide inhibitors of cyclin dependent kinases
09/18/2002	CN1370173A Isomeric fused pyrrolocarbazoles and isoindolones
09/18/2002	CN1370168A Novel spiro compounds
09/12/2002	WO2002069989A2 Aquatic animal treatment method and composition containing pimenta extract
09/11/2002	EP1238677A2 Parenteral fat emulsions comprising edetate as preservative
09/11/2002	CN1368963A Pyrimidine-2,4,6-trione metalloproteinase inhibitors
09/10/2002	US6448277 VEGF receptor tyrosine kinase inhibitors
09/10/2002	US6448271 Substituted benzimidazoles and their use as parp inhibitors
09/10/2002	US6448250 Sulfamato hydroxamic acid metalloprotease inhibitor
09/06/2002	WO2002068415A1 Pyrazole compounds useful as protein kinase inhibitors
09/06/2002	WO2002067921A1 Carbamate compounds for use in preventing or treating bipolar disorder
09/05/2002	US20020123520 3',5'-cyclic nucleotide phosphodiesterases (PDEs); disease related to eosinophils, such as asthma, chronic bronchitis, and chronic obstructuive pulmonary disease
09/04/2002	EP1235831A2 New oxabispidine compounds useful in the treatment of cardiac arrhythmias

1 ... 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32